Refining CFTR-Related Metabolic Syndrome (CRMS)/Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID) Diagnosis: Impact of CFTR2 Variant Classifications. This evidence concerns the gene CFTR and CFTR-related metabolic syndrome/CF screen positive, inconclusive diagnosis.